Every story in this section, newest first — page 147 of 373.
Biotechnology firm bioAffinity Technologies (NASDAQ:BIAF) announced preclinical findings showing its novel small interfering RNA therapeutic approach selectively destroys cells from two common skin cancers that affect an estimated 5.4 million annual United States cases.
Booz Allen Hamilton (NYSE:BAH) executed a definitive agreement to acquire Ultra I&C Mission Solutions for $720 million to expand its defense technology portfolio.
Worksport (NASDAQ:WKSP) announced a preliminary gross margin of approximately 35% for the month of May 2026.
Outdoor Holding Company (NASDAQ:POWW) reported a 10.1% increase in fourth-quarter revenue to $13.9 million.
Palvella Therapeutics (NASDAQ:PVLA) announced that the FDA granted rolling review for its rare genetic disease drug application.
Organon (NYSE:OGN) finalized a global licensing agreement with Sebela Pharmaceuticals for a hormone-free birth control device that is 99% effective.
REGENXBIO (NASDAQ:RGNX) aligned with the FDA to resubmit its rare disease drug application in Q3 2026.
MapLight (NASDAQ:MPLT) announced that its Phase 2 autism trial of 161 patients missed its primary efficacy endpoint.
CRH (NYSE:CRH) signed a definitive agreement to purchase competitor Arcosa for $150 per share in cash.
Fervo Energy (NASDAQ:FRVO) reported a first-quarter net loss of $31.8 million while funding multiple utility-scale geothermal facilities.
Galmed Pharmaceuticals (NASDAQ:GLMD) closed its Colospan acquisition, gaining a device tested on 97 patients.
Definium Therapeutics (NASDAQ:DFTX) stated its depression drug trial succeeded, showing a key 8.1-point improvement over a placebo.
AbbVie (NYSE:ABBV) executed an agreement to acquire Apogee Therapeutics (NASDAQ:APGE) for $135.11 per share in cash, totaling approximately $10.9 billion.
Dr. Wolfgang Pinegger, owner and creator of the GloBra ecosystem, has published SHIFT!. The book describes his life as one of relentless reinvention, from shop floors to blockchains, and from a small Austrian village to travelling the world.
The book works as both memoir and guide to navigating change in business and in life.
HawkEye 360 (NYSE:HAWK) achieved record first-quarter 2026 revenue of $49.8 million due to strong global demand.
Merck (NYSE:MRK) announced positive topline results from its Phase 3 study evaluating tulisokibart for active ulcerative colitis.
Ennis (NYSE:EBF) reported a 1.4% increase in first-quarter revenue to $98.6 million for the period ended May 31, 2026.
Petróleo Brasileiro, also known as Petrobas (NYSE:PBR) approved the final investment decision for a $1.2 billion biorefining project to produce renewable fuels.
Baker Hughes (NASDAQ:BKR) is discussing potential commitments with the European Commission to clear its acquisition of Chart Industries (NYSE:GTLS).
MOGU (NYSE:MOGU) posted an 11.2% decline in fiscal year 2026 total revenues to RMB125.4 million due to heightened competition.
ECARX (NASDAQ:ECX) signed a definitive agreement to acquire the Flyme software business for RMB1.8 billion ($266 million)
HF Foods Group (NASDAQ:HFFG) expanded its board from four to five members by appointing Taylor S. Brown.
British Prime Minister Keir Starmer resigned outside Downing Street as the British Pound fell below $1.32.
Brent Crude fell 0.91% to $79.12 a barrel after initial US-Iran peace negotiations concluded with encouraging progress.
